|
End-of-day quote
Egyptian Exchange
27/10/2026
|
5-day change | 1st Jan Change | ||
| 258.24 EGP | +14.81% |
|
-8.46% | +305.72% |
| 08-13 | GlaxoSmithKline S.A.E Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 05-17 | GlaxoSmithKline Q1 consol net profit EGP 4.7 million | RE |
Stock exchange
Egyptian Exchange
BIOC 258.24 £
+14.81%
54.87M
£
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| BIOC | 258.24EGP | +14.81% | 54.87M £ |
Quotes 5-day view: GlaxoSmithKline S.A.E
End-of-day quote Egyptian Exchange| 21/10/2026 | 22/10/2026 | 25/10/2026 | 26/10/2026 | 27/10/2026 | |
|---|---|---|---|---|---|
| Last | EGP 273.44 | EGP 260.03 | EGP 218.14 | EGP 224.92 | EGP 258.24 |
| Volume | 65,976 | 115,186 | 91,517 | 172,393 | 212,484 |
| Change | -3.07% | -4.90% | -16.11% | +3.11% | +14.81% |
| Opening | EGP 282.10 | EGP 273.44 | EGP 260.03 | EGP 218.14 | EGP 224.92 |
| High | EGP 285.00 | EGP 277.50 | EGP 261.00 | EGP 239.94 | EGP 260.00 |
| Low | EGP 270.10 | EGP 257.21 | EGP 213.00 | EGP 212.05 | EGP 226.30 |
Performance
| 1 day | +14.81% | ||
| 1 week | -8.46% | ||
| Current month | -19.71% | ||
| 1 month | +8.34% | ||
| 3 months | +80.84% | ||
| 6 months | +279.88% | ||
| Current year | +305.72% | ||
| 1 year | +250.73% | ||
| 3 years | +690.21% | ||
| 5 years | +1,133.83% | ||
| 10 years | +2,213.98% |
Volumes
marketsDaily volume
212,484
Avg. Volume 20 sessions
228,239
Avg. Volume 20 sessions EGP
58,940,439.36
Avg. Volume 20 sessions USD
1,051,025.91
Record volume 1
2,414,902
Record volume 2
1,829,945
Record volume 3
1,576,204
Capital turnover ratio
0
Float rotation
0.09
Basic data
Market Cap (EGP)
21,566,706,993
Market Cap (USD)
384,433,965
Net sales ()
3,730,502,257
Net sales (USD)
66,497,485
Free-Float
2.91%
Free-Float capitalization (EGP)
628,626,401
Free-Float capitalization (USD)
11,205,482
Average Daily Capital Traded
0.27%
Indicators
Moving average 5 days
246.95
Moving average 20 days
294.06
Moving average 50 days
322.3
Moving average 100 days
245.12
Price spread / (MMA5)
-4.37%
Price spread / (MMA20)
+13.87%
Price spread / (MMA50)
+24.81%
Price spread / (MMA100)
-5.08%
RSI 9 days
43.67
RSI 14 days
43.57
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +14.81% | -8.46% | +250.73% | +690.21% | 384M | |
| +0.22% | -0.14% | +55.12% | +128.82% | 1,143B | |
| +0.91% | +3.61% | +41.21% | +84.57% | 647B | |
| -0.12% | -0.93% | +25.59% | +106.14% | 506B | |
| -0.95% | +0.99% | +51.63% | +64.07% | 384B | |
| +0.86% | -4.37% | +61.16% | +37.93% | 350B | |
| +0.75% | +2.41% | +31.43% | +53.54% | 293B | |
| -0.51% | +1.41% | +3.11% | +25.19% | 265B | |
| +0.75% | +2.05% | +53.85% | +71.25% | 242B | |
| +0.25% | +1.64% | +32.05% | +107.62% | 197B | |
| Average | +1.54% | +0.20% | +60.59% | +136.93% | 402.79B | |
| Weighted average by Cap. | -0.00% | +0.71% | +43.04% | +88.05% |
Historical Quotes: GlaxoSmithKline S.A.E
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 1 week | 212.05 |  | 277.5 |
| 1 month | 212.05 | | 380 |
| Current year | 55.1 | | 609 |
| 1 year | 55.1 | | 609 |
| 3 years | 24.7 | | 609 |
| 5 years | 18.7 | | 609 |
| 10 years | 0 | | 609 |
Monthly variations
Annual variations
| 2026 | +305.72% | ||
| 2025 | +76.81% | ||
| 2024 | +1.27% | ||
| 2023 | -6.84% | ||
| 2022 | +23.58% | ||
| 2021 | +82.08% | ||
| 2020 | -14.17% | ||
| 2018 | -100.00% | ||
| 2017 | +81.72% | ||
| 2016 | -11.39% | ||
| 2015 | -10.00% | ||
| 2014 | -20.11% | ||
| 2013 | +53.22% | ||
| 2012 | +0.42% | ||
| 2011 | -39.24% | ||
| 2010 | +18.18% | ||
| 2009 | +24.72% | ||
| 2008 | -47.68% | ||
| 2007 | +0.89% | ||
| 2006 | +104.33% | ||
| 2005 | +6.65% |
- Stock Market
- Stocks
- BIOC Stock
- Quotes GlaxoSmithKline S.A.E
Select your edition
All financial news and data tailored to specific country editions
